Skip to content

COVID-19 Booster Readiness Survey

COVID-19 Booster Readiness Survey

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05529030
Enrollment
12036
Registered
2022-09-06
Start date
2022-09-01
Completion date
2022-09-15
Last updated
2022-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaccination Refusal

Keywords

Communication, Surveys and Questionnaires, Vaccination, Economics, Behavioral

Brief summary

The purpose of this administrative survey is to inform health system logistics by assessing the attitudes towards towards the bivalent COVID-19 boosters held by healthcare workers (HCWs) at a large, rural health system. It will also test, prospectively, the effect on interest in the bivalent COVID-19 booster of different framing approaches in a survey question sent to employees of a large, rural health system.

Detailed description

The Food and Drug Administration has authorized two bivalent COVID-19 boosters with the expectation that the Centers for Disease Control will soon recommend them. The researchers plan to survey the HCWs at a large, rural health system on their attitudes on the bivalent booster. This survey will gather data on HCWs' interest in a bivalent booster, reasons for hesitancy, risk perception about COVID-19 infection and its complications, and prior COVID-19 infection and vaccination. Respondents will also be randomly assigned to see different versions of the question asking if they are interested in a bivalent booster with different framing approaches, such as protection of the self or protection of patients (for patient-facing employees). Information on prior vaccination and perceptions of risk will also be gathered and used as covariates in the analysis.

Interventions

BEHAVIORALSalience of Omicron variant

The message mentions the Omicron variant, which can be a fear appeal or make salient the reason for the new booster

BEHAVIORALSelf-protection message

The message makes a reference to protecting one's self

BEHAVIORALOther-protection message

The message makes a reference to protecting others (patients)

Sponsors

Geisinger Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Participants will not know that there are different versions of surveys

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Employee at the health system

Design outcomes

Primary

MeasureTime frameDescription
Count of employees who indicate interest in the booster14 daysNumber of employees who indicate that they plan to get the booster when it is available

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026